—

Print
Save
Email this link

Share Link

Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:

https://erc.bioscientifica.com/search?access=all&pageSize=10&q=%22high-grade%22&sort=relevance&t=ERC-PPGL-collection
The link was not copied. Your current browser may not support copying via this button.

Link copied successfully

Search Results

You are looking at 1 - 1 of 1 items for :

"high-grade" x

Advances and Future Directions in Pheochromocytoma and Paraganglioma x

Refine by access: All content x

Clear All

Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine

David Taïeb

David Taïeb Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by David Taïeb in
Google Scholar
PubMed

Christelle Fargette

Christelle Fargette Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by Christelle Fargette in
Google Scholar
PubMed

Abhishek Jha

Abhishek Jha Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Abhishek Jha in
Google Scholar
PubMed

, and

Karel Pacak

Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed

of nine have received previous 177 Lu-PRRT. A reduction or interruption of antihypertensive drugs was been observed in 3/7 and 2/7, respectively. No high-grade toxicity was observed. More recently, data from phase 1 using Pb212 as in vivo generator